At a glance

ClinicalIndex Comparison Record

Phase 2Completed

Drug / intervention

fenfluramine +1 moredrug

Likely dose

Not stated in record

Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000506

NCT00000506Phase 2Completed

Compare CT.gov

Cardiovascular System in Obesity: Effect of Treatment

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Nov 26, 2013

In Brief

A Phase 2 clinical trial evaluating fenfluramine and phentermine for Heart Diseases and 2 related conditions. Completed.

Detailed Summary

To determine the long-term efficacy of the combination therapy of phentermine and fenfluramine in conjunction with diet, exercise, and behavior modification in the treatment of simple, moderate obesity.

Study Details

Study Typeinterventional

Allocation--

Masking--

Primary Purpose--

ConditionsHeart Diseases, Obesity, Vascular Diseases

Countries--

Collaborators--

Timeline

Phase 2CompletedFinished

198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027

Enrollment StartMay 1983

Study CompletionApr 1988

First PostedOct 1999

TodayJul 2026

First PostedOct 28, 1999

Enrollment StartMay 1, 1983

Study CompletionApr 1, 1988

TodayJul 2, 2026

Posted 26.7 years ago

Interventions

fenfluraminedrug

phenterminedrug